These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16594621)

  • 21. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
    Yau EH; Butler MC; Sullivan JM
    Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribozyme- and deoxyribozyme-strategies for medical applications.
    Schubert S; Kurreck J
    Curr Drug Targets; 2004 Nov; 5(8):667-81. PubMed ID: 15578948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and optimization of sequence-specific hairpin ribozymes.
    Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
    Methods Mol Biol; 2004; 252():327-38. PubMed ID: 15017061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of strategies for conditional RNA interference.
    Allen D; Kenna PF; Palfi A; McMahon HP; Millington-Ward S; O'Reilly M; Humphries P; Farrar GJ
    J Gene Med; 2007 Apr; 9(4):287-98. PubMed ID: 17397092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Concepts for RNA Therapeutics for Inherited Retinal Disease.
    Moore SM; Skowronska-Krawczyk D; Chao DL
    Adv Exp Med Biol; 2019; 1185():85-89. PubMed ID: 31884593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antisense sequence of the HIV-1 TAR stem-loop structure covalently linked to the hairpin ribozyme enhances its catalytic activity against two artificial substrates.
    Pérez-Ruiz M; Sievers D; García-López PA; Berzal-Herranz A
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):33-42. PubMed ID: 10192287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleic acid enzymes as a novel generation of anti-gene agents.
    Sioud M
    Curr Mol Med; 2001 Nov; 1(5):575-88. PubMed ID: 11899232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA double cleavage by a hairpin-derived twin ribozyme.
    Schmidt C; Welz R; Müller S
    Nucleic Acids Res; 2000 Feb; 28(4):886-94. PubMed ID: 10648779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic antisense and ribozymes.
    Rossi JJ
    Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes and siRnas: from structure to preclinical applications.
    Sioud M
    Handb Exp Pharmacol; 2006; (173):223-42. PubMed ID: 16594618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of c-Ha-ras gene expression by hammerhead ribozymes containing a stable C(UUCG)G hairpin loop.
    Koizumi M; Kamiya H; Ohtsuka E
    Biol Pharm Bull; 1993 Sep; 16(9):879-83. PubMed ID: 8268855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNAs Biogenesis in Eukaryotes Through Self-Cleaving Hammerhead Ribozymes.
    de la Peña M
    Adv Exp Med Biol; 2018; 1087():53-63. PubMed ID: 30259357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
    Kim YK; Junn E; Park I; Lee Y; Kang C; Ahn JK
    Biochem Biophys Res Commun; 1999 Apr; 257(3):759-65. PubMed ID: 10208856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and anti-HIV-1 activity of hammerhead and hairpin ribozymes containing a stable loop.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleosides Nucleotides; 1998; 17(1-3):207-18. PubMed ID: 9708348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hairpin ribozyme: discovery, two-dimensional model, and development for gene therapy.
    Hampel A
    Prog Nucleic Acid Res Mol Biol; 1998; 58():1-39. PubMed ID: 9308362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribozymes: structure, characteristics and use as potential antiviral agents.
    Bartolomé J; Madejón A; Carreño V
    J Hepatol; 1995; 22(1 Suppl):57-64. PubMed ID: 7602079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.